IPCA Laboratories P/B Ratio
IPCA Laboratories (IPCALAB) P/B ratio is 6.2 (High), book value per share ₹3809.60 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read IPCALAB ex-dividend dates for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
IPCALAB P/B Ratio — Valuation Insights & Book Value Analysis
IPCA Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 6.2 (High). For live price, earnings yield and the full fundamental profile, see IPCALAB stock price BSE.
- Stock appears overvalued with PB of 6.2, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 1219.1% above historical average
- Trading at premium to sector average PB of -0.01
IPCA Laboratories P/B Ratio Historical Trend
IPCALAB annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore IPCALAB value investing to estimate fundamental worth using multiple valuation models.
IPCALAB Historical P/B Ratio — Book Value Per Share & Year-End Price
IPCA Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.53 | ₹3809.6 | ₹2009.60 | ₹9,524 | Low |
| 2025 | 0.42 | ₹3355.2 | ₹1418.90 | ₹8,388 | Low |
| 2024 | 0.55 | ₹3090.8 | ₹1695.20 | ₹7,727 | Low |
| 2023 | 0.47 | ₹2366.0 | ₹1113.15 | ₹5,915 | Low |
| 2022 | 0.38 | ₹2227.6 | ₹843.10 | ₹5,569 | Low |
IPCALAB vs Healthcare Peers — P/B Ratio Comparison
IPCA Laboratories P/B 6.2 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |